# US 2016/0354136 A1 · Apparatus and Methods for Treating Rhinitis

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0354136 A1
- Document ID: US20160354136A1
- Status: Published application
- Kind: A1
- Application number: 15/242,398
- Filed: 2016-08-19
- Published: 2016-12-08
- Earliest claimed: 2013-09-30
- Assignees: Nidus Medical, LLC
- Applicants: Nidus Medical, LLC
- Inventors: Vahid Saadat
- Web page: https://patentgrep.com/patent/US20160354136A1

## CPC

- A61B 18/1485: {having a short rigid shaft for accessing the inner body through natural openings}
- A61B 17/24: for use in the oral cavity, larynx, bronchial passages or nose (for medical inspection of cavities or tubes in the body A61B1/00); Tongue scrapers
- A61B 18/02: by cooling, e.g. cryogenic techniques
- A61N 7/02: Localised ultrasound hyperthermia
- A61N 7/022: {intracavitary}
- A61B 2018/0022: {Balloons}
- A61B 2018/00327: {Ear, nose or throat}
- A61B 2018/00434: {Neural system}
- A61B 2018/00577: {Ablation}
- A61B 2018/00714: {Temperature}
- A61B 2018/00791: {Temperature}
- A61B 2018/00982: {combined with or comprising means for visual or photographic inspections inside the body, e.g. endoscopes}
- A61B 2018/0212: {using an instrument inserted into a body lumen, e.g. catheter}
- A61B 2018/0268: {with restriction of flow}
- A61B 2018/143: {multiple needles}
- A61B 2018/1475: {Electrodes retractable in or deployable from a housing}
- A61B 2090/378: {using ultrasound}
- A61B 2218/002: Irrigation
- A61N 2007/003: {Destruction of nerve tissue}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)

## Abstract

Apparatus and methods for treating conditions such as rhinitis are disclosed herein where a distal end of a probe shaft is introduced through the nasal cavity where the distal end has an end effector with a first configuration having a low-profile which is shaped to manipulate tissue within the nasal cavity. The distal end may be positioned into proximity of a tissue region having a post nasal nerve associated with a middle or inferior nasal turbinate. Once suitably positioned, the distal end may be reconfigured from the first configuration to a second configuration which is shaped to contact and follow the tissue region and the post nasal nerve may then be ablated via the distal end. Ablation may be performed using various mechanisms, such as cryotherapy, and optionally under direct visualization.

## Claims

### Claim 1

A method for treating rhinitis in a tissue region within a nasal cavity, comprising:
introducing a distal end of a probe shaft through the nasal cavity, wherein the distal end has an end effector with a first configuration having a low-profile which is shaped to manipulate tissue within the nasal cavity;
positioning the distal end into proximity of a tissue region having at least one posterior nasal nerve associated with a middle or inferior nasal turbinate;
reconfiguring the distal end from the first configuration to a second configuration which is shaped to contact and follow the tissue region; and
cryo-ablating the at least one posterior nasal nerve within the tissue region via the distal end such that at least one symptom of rhinitis is reduced.

### Claim 2 (depends on 1)

The method of claim 1 wherein the end effector comprises an expandable structure and reconfiguring comprises introducing a cryogenic fluid into the expandable structure such that the expandable structure is inflated from a deflated configuration into an expanded configuration against the tissue region.

### Claim 3 (depends on 2)

The method of claim 2 wherein introducing the cryogenic fluid comprises evaporating the cryogenic fluid within the expandable structure.

### Claim 4 (depends on 1)

The method of claim 1 wherein positioning the distal end comprises positioning the distal end at least 2 cm beyond an anterior entrance to a middle meatus.

### Claim 5 (depends on 1)

The method of claim 1 wherein positioning the distal end comprises:
advancing the distal end along an upper surface of the inferior nasal turbinate to a mid-portion of the middle nasal turbinate;
advancing the distal end into a middle meatus; and
further advancing the distal end posteriorly up into a cul-de-sac.

### Claim 6 (depends on 1)

The method of claim 1 wherein positioning the distal end comprises positioning the distal end between the middle and inferior nasal turbinate.

### Claim 7 (depends on 1)

The method of claim 1 wherein positioning the distal end comprises positioning the distal end relative to the tissue region surrounded by the middle nasal turbinate, inferior nasal turbinate, and lateral nasal wall.

### Claim 8 (depends on 1)

The method on claim 1 wherein positioning the distal end further comprises applying lateral pressure against a nasal wall tissue region with the end effector while positioning the distal end of the probe.

### Claim 9 (depends on 1)

The method of claim 1 wherein positioning the distal end comprises positioning the distal end into proximity of the Pterygomaxillary fossa, sphenopalatine ganglion, sphenopalatine ganglion, or vidian nerve.

### Claim 10 (depends on 1)

The method of claim 1 wherein positioning the distal end comprises positioning the distal end into proximity of accessory posterolateral nerves bounded by an sphenopalatine foramen superiorly, an inferior edge of an inferior turbinate inferiorly, a Eustachian tube posteriorly, or a posterior third of the middle and inferior turbinates anteriorly.

### Claim 11 (depends on 1)

The method of claim 1 wherein reconfiguring the distal end comprises inflating an expandable structure projecting from the probe shaft into contact against the tissue region.

### Claim 12 (depends on 11)

The method of claim 11 further comprising positioning a member extending within the expandable structure, wherein the expandable structure encloses the member such that the member is unattached to an interior of the expandable structure, into contact against the tissue region through the expandable structure.

### Claim 13 (depends on 1)

The method of claim 1 further comprising introducing an agent prior to or during the cryo-ablation.

### Claim 14 (depends on 1)

The method of claim 1 further comprising introducing an imaging device in proximity to the distal end.

### Claim 15

A method for treating rhinitis, comprising:
introducing a distal end of a probe shaft through the nasal cavity, wherein the distal end has an end effector with a first configuration having a low-profile which is shaped to manipulate tissue within the nasal cavity;
positioning the distal end into proximity of a tissue region surrounded by a middle nasal turbinate, inferior nasal turbinate, and lateral wall and having at least one posterior nasal nerve associated with the middle or inferior nasal turbinate;
reconfiguring the distal end from the first configuration to a second configuration which is shaped to contact and follow the tissue region; and
ablating the at least one posterior nasal nerve within the tissue region via the distal end such that at least one symptom of rhinitis is reduced.

### Claim 16 (depends on 15)

The method of claim 15 wherein introducing a distal end comprises introducing the distal end through a nostril and into the nasal cavity.

### Claim 17 (depends on 15)

The method of claim 15 wherein positioning the distal end comprises positioning the distal end at least 2 cm beyond an anterior entrance to a middle meatus.

### Claim 18 (depends on 15)

The method of claim 15 wherein positioning the distal end comprises:
advancing the distal end along an upper surface of the inferior nasal turbinate to a mid-portion of the middle nasal turbinate;
advancing the distal end into a middle meatus; and
further advancing the distal end posteriorly up into a cul-de-sac.

### Claim 19 (depends on 15)

The method of claim 15 wherein positioning the distal end comprises positioning the distal end between the middle and inferior nasal turbinate.

### Claim 20 (depends on 15)

The method on claim 15 wherein positioning the distal end comprises positioning the distal end to contact a lateral nasal wall defined by the nasal turbinate, lateral wall, and an inferior turbinate.

### Claim 21 (depends on 15)

The method of claim 15 wherein positioning the distal end comprises positioning the distal end into proximity of the Pterygomaxillary fossa, sphenopalatine ganglion, sphenopalatine ganglion, or vidian nerve.

### Claim 22 (depends on 15)

The method of claim 15 wherein positioning the distal end comprises positioning the distal end into proximity of accessory posterolateral nerves bounded by an sphenopalatine foramen superiorly, an inferior edge of an inferior turbinate inferiorly, a Eustachian tube posteriorly, or a posterior third of the middle and inferior turbinates anteriorly.

### Claim 23 (depends on 15)

The method of claim 15 wherein the end effector comprises an expandable structure and reconfiguring the distal end comprises inflating the expandable structure projecting from the probe shaft into contact against the tissue region by introducing a cryogenic fluid into the expandable structure such that the expandable structure is inflated from a deflated configuration into an expanded configuration upon evaporation of the cryogenic fluid within an interior of the expandable structure.

### Claim 24 (depends on 15)

The method of claim 15 further comprising positioning a member extending within the end effector, wherein the end effector encloses the member such that the member is unattached to an interior of the end effector, into contact against the tissue region through the end effector.

### Claim 25 (depends on 15)

The method of claim 15 wherein ablating comprises cryogenically ablating the at least one posterior nasal nerve by introducing a cryogenic fluid into or through the distal end.

### Claim 26 (depends on 15)

The method of claim 15 wherein ablating comprises delivering radio frequency energy to ablate the at least one posterior nasal nerve.

### Claim 27 (depends on 15)

The method of claim 15 wherein ablating comprises delivering ultrasonic energy to ablate the at least one posterior nasal nerve.

### Claim 28 (depends on 15)

The method of claim 15 further comprising introducing an agent prior to or during the ablation.

### Claim 29 (depends on 15)

The method of claim 15 further comprising introducing an imaging device in proximity to the distal end.
